- Home
- EXEL vs CTRE Comparison
EXEL vs CTRE Comparison
Compare EXEL & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | CTRE |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.8B |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | EXEL | CTRE |
|---|---|---|
| Price | $50.11 | $41.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 10 |
| Target Price | ★ $46.50 | $42.40 |
| AVG Volume (30 Days) | ★ 2.7M | 1.7M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.44% |
| EPS Growth | 57.95 | ★ 96.25 |
| EPS | ★ 0.79 | 0.36 |
| Revenue | $452,477,000.00 | ★ $476,393,000.00 |
| Revenue This Year | $13.61 | $5.97 |
| Revenue Next Year | $13.13 | $13.39 |
| P/E Ratio | ★ $64.65 | $116.50 |
| Revenue Growth | N/A | ★ 60.79 |
| 52 Week Low | $33.76 | $27.82 |
| 52 Week High | $51.63 | $43.08 |
Technical Indicators
Market Signals| Indicator | EXEL | CTRE |
|---|---|---|
| Relative Strength Index (RSI) | 63.40 | 57.36 |
| Support Level | $40.17 | $35.77 |
| Resistance Level | N/A | $41.72 |
| Average True Range (ATR) | 1.60 | 1.00 |
| MACD | 0.51 | 0.25 |
| Stochastic Oscillator | 82.66 | 55.05 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.